Currently in clinic the screening and early diagnosis of lung cancer relies mainly on chest X-ray, low-dose computed tomography, bronchoscopy, sputum cytology, and tumor markers including carcinoembryonic antigen (CEA), cytokeratin-19 fragments (Cyfra21-1), carbohydrate antigen 19-9 (CA19-9), squamous cell carcinoma antigen (SCCAg) and neuron-specific enolase (NSE), etc [2]. The gene discussed is CEACAM5; the disease is neoplasm.